Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results87% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (3)
Early P 1 (1)
P 1 (4)
P 2 (7)
P 3 (2)

Trial Status

Completed13
Unknown2
Withdrawn2
Terminated2
Active Not Recruiting1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT04219904Early Phase 1Active Not Recruiting

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

NCT03198286Not ApplicableCompleted

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

NCT00577317Phase 3Terminated

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

NCT01019278Phase 2Withdrawn

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

NCT02880007Phase 2Completed

Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer

NCT00416455Phase 1Completed

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

NCT00262821Phase 3Terminated

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer

NCT03469531Phase 2Unknown

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

NCT01764802Phase 2Completed

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

NCT01098630Completed

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

NCT00941070Phase 2Completed

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

NCT00460356Completed

Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes

NCT00956670Not ApplicableUnknown

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

NCT00559377Phase 2Completed

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

NCT00897442Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

NCT00104910Phase 1Completed

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

NCT00054444Phase 1Completed

Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer

NCT00068549Phase 1Completed

Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

NCT00107445Phase 2Completed

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

NCT01313104Not ApplicableWithdrawn

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Showing all 20 trials

Research Network

Activity Timeline